C9orf72 and amyotrophic lateral sclerosis: Preliminary evidence suggested that the C9orf72 mutation rates in patients with clinically diagnosed ALS/FTD in China, Japan, Korea, and Taiwan were much lower than that observed in Caucasian populations [16].